Zitter Health Insights
Livingston, N.J. (February 16, 2017) – Zitter Health Insights (ZHI), has been providing life science, specialty pharmacy and managed care organizations insights that optimize patient access to medications for almost three decades. ZHI’s Specialty Pharmacy Patient Satisfaction Survey was created to address an unmet need for an independent and objective benchmarking study that compares patient satisfaction across US specialty pharmacies. These data are used by specialty pharmacies for contracting, accreditation, and to evaluate and improve their services. The data are also used by pharmaceutical companies to monitor patient experiences with the specialty pharmacies that dispense their brands.
Zitter Health Insights has deep expertise designing and conducting large-scale syndicated survey research. The methodology and questions used in the Specialty Pharmacy Patient Satisfaction Survey were developed by our expert survey design team and statisticians in conjunction with an advisory committee. The advisory committee consists of industry thought leaders from specialty pharmacies of varying sizes, pharmaceutical manufacturers, payer organizations, external statisticians and consulting agencies. The survey is designed to provide an accurate and statistically reliable assessment of patient experiences at the specialty pharmacies.
Data are collected quarterly via online surveys completed by patients who obtain medications from specialty pharmacies. The majority of patients surveyed have one of the following conditions: Crohn’s Disease, Cystic Fibrosis, Hepatitis, HIV/AIDs, Hypercholesterolemia, Infertility, Multiple Sclerosis, Oncology, Osteoarthritis, Psoriasis, Pulmonary Arterial Hypertension, Rheumatoid Arthritis, Severe Asthma, Transplant, or Ulcerative Colitis.
Patients are recruited to participate in the survey via two primary methods:
The study report includes data aggregated across all patients surveyed, and also provides pharmacy-level data for any pharmacy evaluated by at least 30 patients.
The data from the Specialty Pharmacy Patient Satisfaction Survey have important ramifications for a variety of stakeholders. This is why so much care has been taken in survey design and implementation. Net Promoter Score is used in this survey since it is a widely accepted measure of customer experience that is used as a core measure of customer satisfaction in a wide range of industries around the world. Coupling the Net Promoter Score measure with the other insights about the customer journey collected in the Specialty Pharmacy Patient Satisfaction Study results in a comprehensive view of pharmacy performance.
The Specialty Pharmacy Patient Choice Award was created by Zitter Health Insights and Specialty Pharmacy Times* to honor specialty pharmacies and their commitment to patients. The criteria for the award were formulated by an external awards committee made up of a diversity of individuals in the healthcare industry. Committee members include:
Specialty pharmacies are eligible for either the PBM/payer-based or non-PBM/payer-based award depending on which of these categories describes the majority of a pharmacy’s patients.
Pharmacies are selected for a Patient Choice Award based on their average Net Promoter Score from all four quarterly surveys conducted each calendar year. Specialty pharmacies for which too few patients completed a survey in a calendar year to make a mean score statistically valid are excluded from consideration. Finalist and Winners are honored at the Asembia Summit for Specialty Pharmacies each year, with the first awards ceremony taking place on May 2, 2017.
*Specialty Pharmacy Times is a journal that focuses on specialty pharmaceuticals and the practice needs of pharmacists in this arena.
# # #
About Zitter Health Insights
Zitter Health Insights (ZHI) combines expert analysis with syndicated subscription research to optimize patient access to pharmaceuticals. Since 1989, ZHI has provided insights to help life science companies, specialty pharmacies, and managed care organizations get the right drugs to the right patients.
Michelle Meppen Rotstain
Zitter Health Insights